Thursday, February 21, 2019
News

Lupin receives FDA approval for generic Nitrofurantoin Capsules USP

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Mumbai | Thursday, Jul 12 2018 IST
Pharma Major, Lupin said that it has received final approval for its Nitrofurantoin Capsules USP (Macrocrystals),50 mg and 100 mg from the United States Food and Drug Administration(FDA) to market a generic version of Alvogen Malta Operations Ltd.'s Macrodantin Capsules, 50 mg and 100 mg.

Lupin's Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg is the generic version of Alvogen Malta Operations Ltd.'s Macrodantin Capsules, 50 mg and 100 mg, company said in a filing with BSE. It is specifically indicated for the treatment of urinary tract infections (UTI) when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.

Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg had annual sales of approximately USD 27 million in the US (IQVIA MAT April 2018).

UNI JS SM SY 1446

-- (UNI) -- C-1-DL0171-1435614.Xml

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Cong wont form govt at Centre, will con...
18 separatists, 155 J&K politicians lose...
Shimla: Snowfall in Kufri, Chharabra dis...
BJP politicising Pulwama terror attack: ...
Amit Shah to launch BJPs beneficiaries ...
J-K: Community bunkers being made forsa...
More...    
 
 Top Stories
Committed to 'free, open Indo-Pacif... 
Fire kills 69 in Bangladesh capital... 
Aurangabad Petrol pumps shut down t... 
Hormonal changes are ruining my lif... 
Guaido, US military leader push Ven... 
Differently-abled senior citizen bu... 
At Lucknow cafe, special kids help ... 
Rocky Star treats every show as his...